156 related articles for article (PubMed ID: 8212321)
21. Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex.
Hatanaka K; Yatsugi S; Yamaguchi T
Eur J Pharmacol; 2000 Apr; 395(1):23-9. PubMed ID: 10781669
[TBL] [Abstract][Full Text] [Related]
22. [5-HT1B serotonin receptors and antidepressant effects of selective serotonin reuptake inhibitors ].
Gardier AM; Trillat AC; Malagié I; David D; Hascoët M; Colombel MC; Jolliet P; Jacquot C; Hen R; Bourin M
C R Acad Sci III; 2001 May; 324(5):433-41. PubMed ID: 11417564
[TBL] [Abstract][Full Text] [Related]
23. Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.
Gartside SE; Clifford EM; Cowen PJ; Sharp T
Br J Pharmacol; 1999 May; 127(1):145-52. PubMed ID: 10369467
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
van Amsterdam C; Seyfried CA
Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
[TBL] [Abstract][Full Text] [Related]
25. Does the addition of pindolol accelerate or enhance the response to selective serotonin reuptake inhibitor antidepressants?
Puzantian T; Kawase K
Pharmacotherapy; 1999 Feb; 19(2):205-12. PubMed ID: 10030770
[TBL] [Abstract][Full Text] [Related]
26. Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram.
Millan MJ; Gobert A; Rivet JM; Adhumeau-Auclair A; Cussac D; Newman-Tancredi A; Dekeyne A; Nicolas JP; Lejeune F
Eur J Neurosci; 2000 Mar; 12(3):1079-95. PubMed ID: 10762339
[TBL] [Abstract][Full Text] [Related]
27. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM
Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
[TBL] [Abstract][Full Text] [Related]
28. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism.
Dawson LA; Nguyen HQ; Geiger A
Neuropharmacology; 1999 Aug; 38(8):1153-63. PubMed ID: 10462128
[TBL] [Abstract][Full Text] [Related]
29. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
[TBL] [Abstract][Full Text] [Related]
30. Stress- and antidepressant treatment-induced modifications of 5-HT₇ receptor functions in the rat brain.
Tokarski K; Bobula B; Grzegorzewska-Hiczwa M; Kusek M; Hess G
Pharmacol Rep; 2012; 64(6):1305-15. PubMed ID: 23406741
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonists.
Zhou D; Stack GP; Lo J; Failli AA; Evrard DA; Harrison BL; Hatzenbuhler NT; Tran M; Croce S; Yi S; Golembieski J; Hornby GA; Lai M; Lin Q; Schechter LE; Smith DL; Shilling AD; Huselton C; Mitchell P; Beyer CE; Andree TH
J Med Chem; 2009 Aug; 52(15):4955-9. PubMed ID: 19719241
[TBL] [Abstract][Full Text] [Related]
32. On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA.
Green AR; McGregor IS
Psychopharmacology (Berl); 2002 Aug; 162(4):448-50. PubMed ID: 12224536
[No Abstract] [Full Text] [Related]
33. Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter.
Troelsen KB; Nielsen EØ; Mirza NR
Psychopharmacology (Berl); 2005 Oct; 181(4):741-50. PubMed ID: 16032412
[TBL] [Abstract][Full Text] [Related]
34. WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity.
Brennan JA; Graf R; Grauer SM; Navarra RL; Pulicicchio CM; Hughes ZA; Lin Q; Wantuch C; Rosenzweig-Lipson S; Pruthi F; Lai M; Smith D; Goutier W; van de Neut M; Robichaud AJ; Rotella D; Feenstra RW; Kruse C; Broqua P; Beyer CE; McCreary AC; Pausch MH; Marquis KL
J Pharmacol Exp Ther; 2010 Jan; 332(1):190-201. PubMed ID: 19828876
[TBL] [Abstract][Full Text] [Related]
35. Do selective serotonin reuptake inhibitors acutely increase frontal cortex levels of serotonin?
Beyer CE; Cremers TI
Eur J Pharmacol; 2008 Feb; 580(3):350-4. PubMed ID: 18177637
[TBL] [Abstract][Full Text] [Related]
36. The effects of LPM570065, a novel triple reuptake inhibitor, on extracellular serotonin, dopamine and norepinephrine levels in rats.
Zhang R; Li X; Shi Y; Shao Y; Sun K; Wang A; Sun F; Liu W; Wang D; Jin J; Li Y
PLoS One; 2014; 9(3):e91775. PubMed ID: 24614602
[TBL] [Abstract][Full Text] [Related]
37. A brain microdialysis study on 5-HT release in freely moving rat lines selectively bred for differential 5-HT1A receptor function.
Gonzalez LE; Parada MA; Tucci S; Teneud L; Overstreet DH; Hernandez L
Braz J Med Biol Res; 2003 Feb; 36(2):263-7. PubMed ID: 12563529
[TBL] [Abstract][Full Text] [Related]
38. Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies.
Gardier AM; Malagié I; Trillat AC; Jacquot C; Artigas F
Fundam Clin Pharmacol; 1996; 10(1):16-27. PubMed ID: 8900496
[TBL] [Abstract][Full Text] [Related]
39. Chronic clomipramine and triiodothyronine increase serotonin levels in rat frontal cortex in vivo: relationship to serotonin autoreceptor activity.
Gur E; Lerer B; Newman ME
J Pharmacol Exp Ther; 1999 Jan; 288(1):81-7. PubMed ID: 9862756
[TBL] [Abstract][Full Text] [Related]
40. In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies.
Bel N; Artigas F
J Pharmacol Exp Ther; 1996 Sep; 278(3):1064-72. PubMed ID: 8819487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
